Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Liver Cancer Market?

The size of the liver cancer market has swiftly expanded in the last few years. It is predicted to surge from $2.94 billion in 2024 to $3.37 billion in 2025, marking a compound annual growth rate (CAGR) of 14.5%. Factors contributing to this historic growth include an increase in the worldwide occurrence of liver cancer, a higher prevalence of hepatitis B and C infections, an uptick in rates of non-alcoholic fatty liver disease, government-led programs encouraging early detection, and heightened public consciousness regarding liver health.

What Growth Rate Is Forecasted for the Liver Cancer Market by 2029?

The market size for liver cancer is predicted to experience rapid expansion in the upcoming years, reaching $5.75 billion by 2029 at a compound annual growth rate (CAGR) of 14.3%. Factors contributing to this growth during the projected period include an increasing elderly population, heightened healthcare spending, amplified demand for minimally intrusive procedures, augmentation of specialty healthcare clinics, and a boost in medical tourism. The forecast period will also witness significant trends such as enhancements in diagnostic technologies, creation of targeted therapies, the introduction of combination treatments, technological progression in surgical methods, and advancements in methods of radiotherapy.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22039&type=smp

Which Key Companies Are Shaping the Future of the Liver Cancer Market?

Major companies operating in the liver cancer market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Novartis AG, Eli Lilly and Company, Siemens Healthineers AG, Terumo Corporation, Eisai Co. Ltd., Qiagen N.V., Exelixis Inc., BeiGene Ltd., RayzeBio Inc., Innovent Biologics Inc., Celsion Corporation

Which Factors Are Driving Demand in the Liver Cancer Industry?

The liver cancer market is anticipated to expand due to the rise in alcohol intake. The term ‘alcohol consumption’ relates to the amount and frequency of alcohol drinks consumed. More and more people are choosing to drink alcohol as it allows them to alleviate everyday tensions, improves social bonding at gatherings, and augments leisure moments. Its promotion through media and increased convenience in many locales also contributes to its popularity. However, high levels of alcohol intake can cause liver cirrhosis, inflammation, and DNA damage, thereby facilitating abnormal cell expansion and significantly heightening the danger of liver cancer. For example, the National Drugs Library, a data collection body based in Ireland, reported in March 2023 that the average alcohol intake for individuals aged 15 and above in 2022 was 10.2 liters of pure alcohol per person, reflecting a rise of 7.6% compared to 2021. As a result, the surge in alcohol consumption propels the market for liver cancer.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=22039&type=smp

How Is the Liver Cancer Market Segmented by Several Divisions?

The liver cancer market covered in this report is segmented –

1) By Type: Hepatoblastoma, Intrahepatic Cholangiocarcinoma, Hepatocellular Carcinoma, Fibrolamellar Carcinoma

2) By Stage Of Liver Cancer: Early Stage, Intermediate Stage, Advanced Stage

3) By Treatment: Targeted Therapy, Radiation Therapy, Surgery, Chemotherapy, Immunotherapy

4) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Cancer Research Institutes

Subsegmentss:

1) By Hepatoblastoma: Epithelial Hepatoblastoma, Mixed Epithelial and Mesenchymal Hepatoblastoma

2) By Intrahepatic Cholangiocarcinoma: Mass-forming Cholangiocarcinoma, Periductal Infiltrating Cholangiocarcinoma, Intraductal Growing Cholangiocarcinoma

3) By Hepatocellular Carcinoma: Fibrolamellar Hepatocellular Carcinoma, Conventional Hepatocellular Carcinoma, Scirrhous Hepatocellular Carcinoma, Clear Cell Hepatocellular Carcinoma, Lymphoepithelioma-like Hepatocellular Carcinoma

4) By Fibrolamellar Carcinoma: Classic Fibrolamellar Carcinoma, Mixed Fibrolamellar and Conventional Hepatocellular Carcinoma

What are the Emerging Market Trends Driving the Growth of the Liver Cancer Industry?

Leading entities in the liver cancer market are prioritizing the creation of novel therapy devices and introducing transcatheter arterial chemoembolization (TACE) to boost treatment accuracy, better patient results, and decrease adverse effects. Transcatheter arterial chemoembolization (TACE) is a low-risk procedure that administers chemotherapy directly to a liver tumor while concurrently inhibiting its blood supply to maximise treatment efficacy. In November 2023, Terumo Corporation, a medical technology firm hailing from Japan, unveiled Occlusafe and LifePearl, two pioneering therapy devices specifically for liver cancer control. These innovative devices aim to streamline the treatment of liver cancer, specifically hepatocellular carcinoma (HCC), the prevalent form of primary liver cancer in India that registers over 20,000 fresh cases each year. Occlusafe forms a key part of a groundbreaking therapy known as Balloon-TACE (B-TACE) that augments the precision and efficacy of TACE through the application of a balloon to obstruct blood flow throughout the procedure. LifePearl consists of polyethylene glycol (PEG) embolization microspheres that can carry chemotherapeutic agents.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/liver-cancer-global-market-report

Which Regions Are Driving Growth in the Liver Cancer Market?

North America was the largest region in the liver cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22039

This Report Delivers Insight On:

1. How big is the liver cancer market, and how is it changing globally?

2. Who are the major companies in the liver cancer market, and how are they performing?

3. What are the key opportunities and risks in the liver cancer market right now?

4. Which products or customer segments are growing the most in the liver cancer market?

5. What factors are helping or slowing down the growth of the liver cancer market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model